Clinical Trials Browser

Hodgkin Disease

Small Cell Lung Carcinoma

Lung Neoplasms, Small Cell Lung Carcinoma

Stomach Neoplasms

Lung Neoplasms

Hodgkin Disease

Lymphoma, Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Lymphoma, Large B-Cell, Diffuse

Small Cell Lung Carcinoma

Lymphoma, B-Cell

Lymphoma, Extranodal NK-T-Cell

Sinonasal Tumors

Unresectable Sinonasal Tumors

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Leukemia, Myeloid, Acute

Ovarian Neoplasms

Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse

Multiple Myeloma

Carcinoma, Ovarian Epithelial

Gestational Trophoblastic Disease

Burkitt Lymphoma, Lymphoma, B-Cell

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Lung Neoplasms, Small Cell Lung Carcinoma

Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Mantle-Cell

Burkitt Lymphoma

Limited Stage Small Cell Lung Cancer

Ovarian Neoplasms

Lymphoma, T-Cell, Peripheral

Lymphoma, Extranodal NK-T-Cell

Extensive Stage Small Cell Lung Cancer

Lymphoma, Extranodal NK-T-Cell

Brain Neoplasms, Breast Neoplasms

Lung Neoplasms, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Lymphoma, T-Cell, Peripheral

Lymphoma, Extranodal NK-T-Cell

Small Cell Lung Cancer Limited Stage

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

Small Cell Lung Carcinoma

Relapsed Pediatric Solid Tumor

Intracranial Non-germinomatous Germ Cell Tumor

Small Cell Lung Carcinoma

Multiple Myeloma

Small Cell Lung Carcinoma

Lung Neoplasms

Clinical Trials

BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)

Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

SVOSA

Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL

NICE-40

R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

STAD-1

Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma

Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NK/T-cell Lymphoma

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients

CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

Natural Killer(NK) Cell Therapy in r/r AML

ACTS

ChiCGB vs BEAM in High-risk or R/R Lymphomas

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

BEAM

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

Natural Killer (NK) Cell Therapy for B-Cell Malignancies

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer

Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma

Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC

GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

A-Plus

Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.

Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer

Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients

the Efficacy and Safety of CLAE in R/R T-ALL/LBL

Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

VIDL+ASCT

CTV

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor

Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer

Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC